Favara B (1992) Hemophagocytic lymphohistiocytosis: A hemophagocytic syndrome. Semin Diagn Pathol 9: 63–74.
[2]
Henter JI, Aricò M, Egeler RM, Elinder G, Favara BE, et al. (1997) HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28: 342–347.
[3]
Aricò M, Janka G, Fischer A, Henter JI, Blanche S, et al. (1983) Hemophagocytic lymphohistiocytosis: Diagnosis, treatment, and prognostic factors. Report of 122 children from the international registry. Leukaemia 10: 197–203.
[No authors listed] (1987) Histiocytosis syndromes in children. The Writing Group of the Histiocyte Society. Lancet 1: 208–209.
[6]
Henter J-I, Elinder G, Ost ？ (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18: 29–33.
[7]
Filipovich AH (2006) Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allerg Clin Immunol 6: 410–415.
[8]
Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, et al. (2003) Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: A report from the HLH study center. Med Pediatr Oncol 41: 103–109.
Gagnaire MH, Galambrun C, Stephan JL (2000) Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children—A series of 12 cases. Pediatrics 106: E58.
[11]
Matzner Y, Behar A, Beeri E, Gunders AE, Hershko C (1979) Systemic leishmaniasis mimicking malignant histiocytosis. Cancer 43: 398–402.
[12]
Bhutani V, Dutta U, Das R, Singh K (2002) Hemophagocytic syndrome as the presenting manifestation of visceral leishmaniasis. J Assoc Physicians India 50: 838–839.
[13]
Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, et al. (1997) Prognostic factors of hemophagocytic syndrome in adults: Analysis of 34 cases. Eur J Haematol 59: 247–253.
[14]
Goldschmidt N, Amir G, Krieger M, Gilead L, Paltiel O (2003) Fatal hemophagocytic syndrome in a patient with panniculitis-like T-cell lymphoma and no clinical evidence of disease. Leuk Lymphoma 44: 1803–1806.
[15]
Craig F, Clare N, Sklar J, Banks P (1991) T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 97: 189–194.
[16]
Jiménez M, Ferrer-Dufol M, Ca？avate C, Gutiérrez-Solar B, Molina R, et al. (1995) Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol Lett 131: 197–204.
[17]
Weisser M, Khanlari B, Terracciano L, Arber C, Gratwohl A, et al. (2007) Visceral leishmaniasis: A threat to immunocompromised patients in non-endemic areas? Clin Microbiol Infect 13: 751–753.
[18]
Castellino G, Govoni M, Lo Monaco A, Montecucco C, Colombo F, et al. (2004) Visceral leishmaniasis complicating a connective tissue disease: Three case reports from Italy. Lupus 13: 201–203.
[19]
Adini I, Ephros M, Chen J, Jaffe CL (2003) Asymptomatic visceral leishmaniasis, northern Israel. Emerg Infect Dis 9: 397–398.
[20]
Bain BJ (2006) Morbidity associated with bone marrow aspiration and trephine biopsy—A review of UK data for 2004. Haematologica 91: 1295–1296.
[21]
Goldschmidt N, Gural A, Kornberg A, Spectre G, Shopen A, et al. (2004) Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia. Am J Hematol 76: 364–367.
[22]
al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124–131.
[23]
Histiocyte Society (2008) Current treatment protocols. Available: http://www.histio.org/site/c.kiKTL4PQLvF？/b.1767369/k.AAF9/Current_Treatment_Prot？ocols.htm. Accessed 18 February 2009.
